PNC Financial Services Group’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117 Sell
5
-5
-50% -$122 ﹤0.01% 5135
2026
Q1
$240 Sell
10
-7
-41% -$183 ﹤0.01% 5017
2025
Q4
$357 Sell
17
-12
-41% -$126 ﹤0.01% 4909
2025
Q3
$289 Buy
+29
New +$327 ﹤0.01% 4896
2021
Q3
Sell
-100
Closed -$4K 4338
2021
Q2
$4K Buy
+100
New +$3.78K ﹤0.01% 3925

Other funds holding GLSI

PNC Financial Services Group's GLSI Position: Q2 2026 in Review

PNC Financial Services Group reduced its Greenwich LifeSciences (GLSI) stake by 50% in Q2 2026, selling an estimated $122 and leaving 5 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #5135.

PNC Financial Services Group first reported a position in GLSI in Q2 2021 and has held it in 5 quarters since. The position peaked at $4K in Q2 2021. 21 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • PNC Financial Services Group held 5 shares of Greenwich LifeSciences worth $117 as of Q2 2026.
  • PNC Financial Services Group sold 5 Greenwich LifeSciences shares in Q2 2026, an estimated $122.
  • Greenwich LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5135 holding.
  • PNC Financial Services Group first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 5 quarters since.
  • PNC Financial Services Group's Greenwich LifeSciences position peaked at $4K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.